How to buy Crinetics Pharmaceuticals (CRNX) shares Tutorial guide

crinetics pharmaceuticals

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is focused on the discovery, development and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotin, a selective non-peptide agonist of the somatostatin receptor type 2 that has completed the phase II clinical trial for the treatment of acromegaly, as well as the completed phase 1 clinical trial to treat carcinoid syndrome. and non-functional neuroendocrine tumors (NETs). The company is also developing CRN04777, a selective oral non-peptide somatostatin receptor type 5 agonist to treat congenital hyperinsulinism, which is in a phase 1 clinical trial; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in a phase 1 clinical trial for the treatment of Cushing’s and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

How to buy Crinetics Pharmaceuticals (CRNX) shares Tutorial guide

Looking for how to buy Crinetics Pharmaceuticals (CRNX) shares on Nasdaq easily and through an officially regulated broker? Does it surprise you to be able to invest your savings per month and get interest on the stock market? Here I am going to show you how you can invest in DeGiro , a reliable Dutch investment broker with minimal commissions, and how you can buy your first share of the company Crinetics Pharmaceuticals, Inc. (CRNX) (CRNX) quickly and simple.

The method to follow is easy to perform :

  • To begin, we will register an account in DEGIRO, a broker platform where we can buy shares of the company Crinetics Pharmaceuticals, Inc. (CRNX), (CRNX).
  • In this step we will enter capital to execute the 1st investment in the stock market.
  • Once we have the funds, we will proceed to search for the company Crinetics Pharmaceuticals with the ticker, in this case it is CRNX.
  • To finish we are only going to adjust the number of shares that we will buy, value and the type of order.

Perhaps the checklist has been essential to you, so we are going to see the entire procedure with screenshots.

How to open a Degiro account

To start we are going to register in DeGiro with this link :

buy shares of Crinetics Pharmaceuticals, Inc. (CRNX)

It will ask us for an email, a username and a password to enter, and then we will have to continue from the link that they have sent us by mail.

Next, Degiro will ask us for some important information to corroborate our document . We will need to have on hand our passport number, ID or driving document, our mobile and the account number that we are going to use to carry out our first deposit. If you don’t understand how this format is, you can check this simple tutorial that we have made from Educacep .

stock Crinetics Pharmaceuticals

Once our account has been validated, we will have to enter money from the Deposit/Withdraw tab. We have the possibility of making a bank transaction that will take one to two days, or carry out the deposit instantly using Sofort, a 100% secure and reliable payment gateway.

wire transfer Crinetics Pharmaceuticals

How to buy Crinetics Pharmaceuticals (CRNX) shares through DEGIRO

When we finally have the money we have the opportunity to buy our first share. You can use the place order button on the top right or use the Degiro search engine and write the ticker. In the following image you will see that I have used the Amazon Ticker but you must enter (CRNX), the Crinetics Pharmaceuticals ticker. Since we are talking about a stock, we will discover that related businesses and companies are listed and there we will look to find Crinetics Pharmaceuticals. The most important thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Crinetics Pharmaceuticals, Inc. (CRNX) is listed on Nasdaq. This step is essential so do not get confused.

American futures exchange Crinetics Pharmaceuticals

When making the order we have to pay special attention to the following . We may place a limit or market order. Imagine that you want to get a share of Crinetics Pharmaceuticals, but its price today is quite high. With the limit order we will place the value at which we calculate to make the purchase and until there are no shares for sale at a certain value, the purchase operation of the share will not be executed. With a to-market order you will buy the number of shares we have suggested at the currently selling price, which will be closely related to the live trading price.

commission limited order Crinetics Pharmaceuticals, Inc. (CRNX)

In one case or another it is very essential that you look at the type of classification: permanent or daily . To serve as an example, in Spain, the stock market is from tomorrow until 1 in the afternoon, and in the United States it corresponds to the afternoon schedule in Spain. If an order is fixed, it will continue until it is executed, but if you choose the “of the day” option, at the end of the day, if it has not been executed, it will be deleted from your Activity tab – Orders in process.

Hopefully this detailed post has helped you to buy shares in Crinetics Pharmaceuticals.

  Company information
  • Crinetics Pharmaceuticals, Inc. (CRNX) Address: Building No. 2 10222 Barnes Canyon Road San Diego, CA 92121 United States 858450 6464 – Website: http://www.crinetics.com
  • Ticker: CRNX
  • Industry: Unknown
  • Industry: Unknown
  • Number of employees: 93
  • Listed market: Nasdaq

key executives

Name Title Salary exercised Year of birth
Dr. R. Scott Struthers Founder, President, CEO and Director 820.33k N/A 1962
Mr. Marc J. C. Wilson Financial director and sec. 527.72k N/A 1979
Dr. Ajay Madan DABT, Ph.D., DABT Chief Develop. Official 567.53k N/A 1968
Dr Yun-Fei Zhu Founder and Vice President of Chemistry N/A N/A 1963
Dr. Stephen F. Betz Co-Founder and Vice President of Biology N/A N/A 1966
Mr. Jeff E. Knight Director of operations N/A N/A N/A
Mrs Garlan Adams General Counsel N/A N/A N/A
Mrs. Adriana Cabre Vice President of Human Resources N/A N/A N/A
Dr. Alan S. Krasner Medical director N/A N/A 1963
Mr Peter Trainer BSc, MBChB, MD, FRCP Vice President of Clinical Endocrinology N/A N/A N/A

Recent events of :

We have no recent events for this company.